Highlands Oncology Group, P.A. v. Hershey Garner, M.D.

2024 Ark. App. 310, 688 S.W.3d 517
CourtCourt of Appeals of Arkansas
DecidedMay 15, 2024
StatusPublished

This text of 2024 Ark. App. 310 (Highlands Oncology Group, P.A. v. Hershey Garner, M.D.) is published on Counsel Stack Legal Research, covering Court of Appeals of Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Highlands Oncology Group, P.A. v. Hershey Garner, M.D., 2024 Ark. App. 310, 688 S.W.3d 517 (Ark. Ct. App. 2024).

Opinion

Cite as 2024 Ark. App. 310 ARKANSAS COURT OF APPEALS DIVISION III No. CV-22-486

Opinion Delivered May 15, 2024

HIGHLANDS ONCOLOGY GROUP, APPEAL FROM THE WASHINGTON P.A. COUNTY CIRCUIT COURT APPELLANT [NO. 72CV-22-1207]

V. HONORABLE DOUG MARTIN, JUDGE HERSHEY GARNER, M.D. APPELLEE AFFIRMED

BRANDON J. HARRISON, Chief Judge

Highlands Oncology Group, P.A. (Highlands) appeals the preliminary injunction

entered in favor of Dr. Hershey Garner. Highlands argues that the circuit court erred by

not following the rule of non-review and by granting Garner’s motion for a preliminary

injunction. We affirm.

I.

Garner is a radiation oncologist who practiced with Northwest Arkansas Radiation

Therapy Institute (NARTI) for approximately twenty years until NARTI was purchased

by Highlands in 2008. Along with being a shareholder in Highlands and a member of its

Board of Directors, Garner entered into an employment agreement with Highlands in 2008;

this agreement gave specific limited terms under which Garner’s employment could be

terminated.

In early 2021, the radiology oncology (rad onc) department had only two physicians, 1 Garner and Chris McClinton. In addition to hiring a third physician in 2021, Garner and

McClinton discussed bringing Garner’s son, Wesley, into the rad onc practice after Wesley

graduated from medical school in 2022. The minutes from the February 2021 executive

committee meeting contain the following language:

Hershey asked if anyone had an issue with Wes joining the practice as his replacement in 2022, and that he and Chris were agreed on that addition. The committee had no objections. It was pointed out that a contract for Wes had not been finalized and so hadn’t been reviewed, and the board would need to be involved in that hiring decision due to Wes Garner being Hershey’s son.

Garner later denied ever saying that Wesley would be his replacement and stated, “I don’t

know how that got in there.”

While the shareholder physicians in the rad onc department generally have authority

over its hiring decisions, Highlands has a company nepotism policy that states, “It is

Highlands Oncology policy that members of your immediate family will not be considered

for employment unless approval is granted by the Board of Directors.” When the decision

about Wesley’s employment came before the Board, Garner was asked not to attend the

board meeting, and he did not object. On 1 March 2021, the Board voted to approve the

hiring of Wesley Garner. That evening, Highlands’ CEO, Jeff Hunnicutt, sent a text to

Garner stating that the Board “voted unanimously to override the nepotism policy and allow

Wes to join Highlands.” On March 4, Garner reviewed the minutes from the March 1

board meeting, which included the following:

There was discussion and agreement that two family members couldn’t effectively or fairly work together in the same department in these positions. Hershey has indicated that Wes will be his replacement, and he will retire prior to Wes’[s] start date.

2 The group determined that this variance to the policy would be granted with the understanding that Hershey will end employment prior to Wes beginning employment. Administration will assist in determining a preferred timing strategy.

A motion was made and seconded that Wes Garner be offered a position as radiation oncologist at Highlands but that there be no overlap of employment between Hershey and Wes. This motion was unanimously approved.

Garner contended that he had never said he would retire before Wesley’s start date

and sought to correct the Board’s misunderstanding about the timing of his retirement. He

texted Hunnicutt and said, “[T]here’s a problem” with the minutes. Hunnicutt responded

that he understood Garner’s confusion because part of his text from March 1 had not gone

through. The message that Garner had not received on March 1 stated, “We will still need

to work through your departure, as the board does want to avoid two family docs working

together.” Garner responded, “We need to revisit that[.] . . . [L]et’s address this sooner

rather than later.”

Garner and Hunnicutt also spoke in person soon after, and Hunnicutt told him that

“the board felt strongly that two family members couldn’t work together in the

department.” Garner responded that was a “non-starter” and that he was not going

anywhere. He suggested a board meeting be convened right away to discuss the concerns

and craft a solution. However, it was decided that the matter would be addressed at the

next regular board meeting. Meanwhile, Highlands executed a contract hiring Wesley, and

Garner signed as a witness to the contract. Garner interpreted the execution of Wesley’s

employment contract as a sign that “we were going to move forward, work together, and

build the department, address the issues, and take care of patients.”

3 The next board meeting was not held until almost a year later on 21 February 2022.

The minutes from that meeting state:

Jeff Hunnicutt informed the group that Hershey had asked for the board to be convened. Hershey Garner told the board that he would like to discuss the decision that he would need to terminate employment when Wes started, in acknowledgement of the no nepotism clause. Hershey said he had recently been surprised to hear from Jeff that he would need to leave by July 1st, and he wanted to know why he couldn’t work with his son. Thad Beck mentioned that Hershey had requested Wes’[s] contract be fast-tracked approximately a year ago, and at that time Hershey had said he would leave when Wes came. Hershey responded that he didn’t recall saying he’d leave immediately, and he would prefer to wind down. . . . [Thad] suggested that Hershey could potentially move into an emeritus role similar to Dr. Hayward where he might be assigned special projects or fill in if requested when a rad onc was on vacation.

....

Dan Bradford stated that the board needed some time to discuss this and suggested another meeting in a month or two.

On 26 May 2022, Garner filed a complaint against Highlands alleging breach of

contract and seeking a preliminary injunction requiring Highlands to maintain his status as

an employee and shareholder of the company during the pendency of the case. In the

complaint, Garner reiterated that Highlands’ policy allows the hiring of immediate family

members if approved by the Board of Directors, and in this case the board had approved

pursuing an employment contract with Wesley. He asserted that Highlands was not firing

him as a result of any action he had taken and that, pursuant to his employment agreement,

Highlands did not have authority to terminate him absent some wrongdoing on his part.

He also expressed extreme concern for his patients, who would have their doctor-patient

relationship with him terminated while undergoing cancer treatment.

Garner also filed a formal motion for a preliminary injunction and an emergency

4 hearing. He argued that Highlands was acting outside any legal authority to terminate him

from his position with Highlands, that the termination will cause irreparable harm not only

to him but, more importantly, to the doctor-patient relationship with those cancer patients

who are relying on him for their care and treatment, and that he has a reasonable probability

of success in the litigation.

The circuit court scheduled a hearing on 8 June 2022. But on June 1, Garner moved

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Manila School District No. 15 v. Wagner
148 S.W.3d 244 (Supreme Court of Arkansas, 2004)
Kreutzer v. Clark
607 S.W.2d 670 (Supreme Court of Arkansas, 1980)
Baptist Health v. Murphy
226 S.W.3d 800 (Supreme Court of Arkansas, 2006)
Brandt v. St. Vincent Infirmary
701 S.W.2d 103 (Supreme Court of Arkansas, 1985)
Holladay v. Glass
2017 Ark. App. 595 (Court of Appeals of Arkansas, 2017)
Baptist Health v. Murphy
2010 Ark. 358 (Supreme Court of Arkansas, 2010)
City of Jacksonville v. Smith
540 S.W.3d 661 (Supreme Court of Arkansas, 2018)
Lakshminarayana Chekuri v. Madhuri Nekkalapudi
2020 Ark. 74 (Supreme Court of Arkansas, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
2024 Ark. App. 310, 688 S.W.3d 517, Counsel Stack Legal Research, https://law.counselstack.com/opinion/highlands-oncology-group-pa-v-hershey-garner-md-arkctapp-2024.